BioCentury
ARTICLE | Strategy

Bristol-Myers calls off Pixykine deal

January 3, 1994 8:00 AM UTC

Bristol-Myers calls off Pixykine deal

Pixykine, Immunex Corp.'s peripatetic molecule in development to boost white blood cell and platelet counts following chemotherapy, has found a new home with American Cyanamid Co...